搜尋結果
Argenx’s Vyvgart Shot Gains US Approval for Rare Nerve Disorder
Bloomberg· 4 小時前Argenx SE’s Vyvgart Hytrulo shot gained US approval to treat a rare nervous system disorder, a ...
South Africa Gets Antiviral Drug to Treat Mpox as Cases Rise
Bloomberg· 1 日前South Africa received its first batch of antiviral drugs to treat mpox as the number of cases ...
Shop Harry & David’s Gourmet Selection of Sweet Treats and Gift Baskets
The Wall Street Journal· 1 日前To access The Journal Collection, sign in using your Dow Jones brand digital subscription. Mark ...
IRS Will Deny Billions Of Dollars Of ‘Clearly Improper’ Employee Retention Credit Claims
Forbes· 1 日前After a detailed review, the IRS says it plans to deny tens of thousands of improper high-risk ...
Eli Lilly expects FDA decision on weight loss drug Zepbound for sleep apnea as early as end of ...
CNBC· 5 小時前Eli Lilly on Friday said it applied for U.S. approval of its weight loss drug Zepbound for the ...
Doctor's recommendation does not bar patient's lawsuit over device -California top court
Reuters· 3 小時前U.S. District Judge R. Gary Klausner in Los Angeles had ruled against plaintiff Michelle ...
Diagnosing Fauci’s Book, On Call: A Doctor’s Journey In Public Service
Forbes· 2 日前Dr. Anthony Fauci has been the most significant figure in healthcare for almost 40 years. ...
US FDA approves Bristol Myers' colorectal cancer therapy
Reuters· 6 小時前The approval under the agency's accelerated process was based on an early- to mid-stage ...
Stocks making the biggest moves premarket: Gilead Sciences, Sarepta Therapeutics, Nike and more
CNBC· 12 小時前The decline comes after the AI chipmaker on Tuesday briefly topped Microsoft as the most ...
Weight-loss drug Zepbound resolves sleep apnea in up to 52% of patients, Lilly says
Reuters· 5 小時前, opens new tab on Friday said its popular weight-loss drug Zepbound helped resolve moderate to ...